24/7 Market News Snapshot 28 August, 2025 – SciSparc Ltd. Ordinary Shares (NASDAQ:SPRC)

August 28, 2025

DENVER, Colo., 28 August, 2025 (www.247marketnews.com) – (NASDAQ:SPRC) are discussed in this article.
SciSparc Ltd. (SPRC), a clinical-stage pharmaceutical company focused on central nervous system therapies, is experiencing notable momentum in the market. Recently, shares have surged by 56.48% in pre-market trading, reaching $6.666, following strong investor interest reflected in a trading volume of 1.74 million shares. This surge comes at a crucial time as SciSparc enhances its business portfolio through a key merger with AutoMax Motors Ltd., a leader in the automotive import sector. Shareholders overwhelmingly approved this strategic merger during an adjourned special general meeting on August 26, 2025.

The merger, formalized on April 11, 2024, involves a reverse merger that will grant SciSparc control of 100% of AutoMax’s share capital. This strategic move is anticipated to create a diversified position within the thriving electric vehicle market, particularly through AutoMax’s established operations in the import and distribution of electric vehicles from Anhui Jianghuai Automobile Group Corp. Ltd. (JAC). Following the merger, it is projected that SciSparc shareholders will maintain approximately 50.01% of the combined enterprise’s equity.

To support its merger efforts, SciSparc has invested significantly in AutoMax, including a $4.25 million bridge loan in 2024, followed by an additional $2 million loan in early 2025. The completion of the merger is subject to standard conditions, including approvals from shareholders of both companies and necessary court endorsements.

A representative from SciSparc expressed enthusiasm regarding the shareholder approval, viewing it as a pivotal step toward enhancing shareholder value through entry into the automotive sector. The upcoming special meetings for AutoMax’s shareholders and non-controlling shareholders of SciSparc, scheduled for August 28, 2025, aim to secure final approvals, laying the groundwork for future growth and sustainability in both the pharmaceutical and automotive industries.

Related news for (SPRC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.